6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with Dyslipidemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kourounakis, AP; Kourounakis, PN; Rekka, EA; Tsiakitzis, KC | 1 |
1 other study(ies) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Dyslipidemia
| Article | Year |
|---|---|
Novel compounds designed as antistress agents.
Topics: Amides; Animals; Anti-Anxiety Agents; Antioxidants; Benzoates; Brain; Carboxylic Acids; Chromans; Drug Design; Dyslipidemias; Esterification; gamma-Aminobutyric Acid; Lipid Peroxidation; Lorazepam; Male; Oxidative Stress; Rats; Stress, Physiological | 2009 |